Why CLEOPATRA Became the Gold Standard in HER2+ Metastatic Breast Cancer

For more than a decade, CLEOPATRA defined first-line treatment for HER2-positive metastatic breast cancer.

In this clip, Drs. Iyengar and Dietrich revisit why it changed everything — and where its limitations still exist, especially in durability and brain metastases.